Europe Drug Eluting Stent Market Size, Share & Industry Trends Analysis Report By Application (Coronary Artery Disease, and Peripheral Artery Disease), By Coating Type, By Country and Growth Forecast, 2023 - 2030

Europe Drug Eluting Stent Market Size, Share & Industry Trends Analysis Report By Application (Coronary Artery Disease, and Peripheral Artery Disease), By Coating Type, By Country and Growth Forecast, 2023 - 2030


The Europe Drug Eluting Stent Market would witness market growth of 8.1% CAGR during the forecast period (2023-2030). In the year 2020, the Europe market's volume surged to 3,989.0 thousand units, showcasing a growth of 7.4% (2019-2022).

Drug-eluting stents (DES) have fundamentally altered and transformed the interventional landscape and made angioplasty more predictable, spurring the market for these devices to expand. By incorporating medication therapy directly into the stent, DES represents a considerable advancement over conventional angioplasty. Numerous advantages of this minimally invasive procedure include decreased stress to blood vessels, quicker recuperation durations, and lower complication risks.

Furthermore, the drug eluting stent market has been focused recently due to increased device development, advancements in adjunctive pharmacology, and improved information systems. Even for the most difficult lesions, restenosis is expected to decline due to quick technological advances in stent design and delivery technologies. The introduction of technologically upgraded stents by major market participants is expected to reduce the incidence of early and late thrombosis.

New avenues for percutaneous coronary interventions in treating cardiovascular diseases have been made possible by developing drug eluting stents. Bioresorbable polymers are being developed and introduced to prevent restenosis, ensure patient safety, and enhance the procedure's therapeutic results. Several market participants have put much effort into R&D and have introduced improved stents made of bioresorbable polymers. The DES ensures minimal tissue injury while enabling quicker vessel repair.

Germany has seen a surge in coronary artery diseases in recent years. More than 800,000 people currently receive invasive diagnostic and therapeutic operations for coronary artery disease (CAD) in Germany each year, according to a Government of Germany article titled The Treatment of Coronary Artery Disease. By the turn of the millennium, 65,000 coronary artery bypass grafting (CABG) procedures were performed annually. These factors will expand the market in the Europe region.

The Germany market dominated the Europe Drug Eluting Stent Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $835 million by 2030. The UK market is exhibiting a CAGR of 7.2% during (2023 - 2030). Additionally, The France market would experience a CAGR of 8.9% during (2023 - 2030).

Based on Application, the market is segmented into Coronary Artery Disease, and Peripheral Artery Disease. Based on Coating Type, the market is segmented into Polymer-based Coating (Non-biodegradable Polymers, and Biodegradable Polymers), and Polymer-free Coating (Micro Porous Surface, Micro Structured Surface, Slotted Tubular Surface, and Nanoporous Surface). Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Terumo Corporation, Medtronic PLC, Biosensors International Group, Ltd. (Blue Sail Medical Co., Ltd.), Cook Medical, Inc. (Cook Group), B. Braun Melsungen AG, Biotronik SE & Co. KG, Lepu Medical Technology Co., Ltd and Alvimedica

Scope of the Study

Market Segments covered in the Report:

By Application (Volume, Thousand Units, USD Million, 2019-2030)
  • Coronary Artery Disease
  • Peripheral Artery Disease
By Coating Type (Volume, Thousand Units, USD Million, 2019-2030)
  • Polymer-based Coating
  • Non-biodegradable Polymers
  • Biodegradable Polymers
  • Polymer-free Coating
  • Micro Porous Surface
  • Micro Structured Surface
  • Slotted Tubular Surface
  • Nanoporous Surface
By Country (Volume, Thousand Units, USD Million, 2019-2030)
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
Companies Profiled
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Terumo Corporation
  • Medtronic PLC
  • Biosensors International Group, Ltd. (Blue Sail Medical Co., Ltd.)
  • Cook Medical, Inc. (Cook Group)
  • B. Braun Melsungen AG
  • Biotronik SE & Co. KG
  • Lepu Medical Technology Co., Ltd
  • Alvimedica
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Drug Eluting Stent Market, by Application
1.4.2 Europe Drug Eluting Stent Market, by Coating Type
1.4.3 Europe Drug Eluting Stent Market, by Country
1.5 Methodology for the research
Chapter 2. Market At a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Force Analysis
Chapter 4. Europe Drug Eluting Stent Market by Application
4.1 Europe Coronary Artery Disease Market by Country
4.2 Europe Peripheral Artery Disease Market by Country
Chapter 5. Europe Drug Eluting Stent Market by Coating Type
5.1 Europe Polymer-based Coating Market by Country
5.2 Europe Drug Eluting Stent Market by Polymer-based Coating Type
5.2.1 Europe Non-biodegradable Polymers Market by Country
5.2.2 Europe Biodegradable Polymers Market by Country
5.3 Europe Polymer-free Coating Market by Country
5.4 Europe Drug Eluting Stent Market by Polymer-free Coating Type
5.4.1 Europe Micro Porous Surface Market by Country
5.4.2 Europe Micro Structured Surface Market by Country
5.4.3 Europe Slotted Tubular Surface Market by Country
5.4.4 Europe Nanoporous Surface Market by Country
Chapter 6. Europe Drug Eluting Stent Market by Country
6.1 Germany Drug Eluting Stent Market
6.1.1 Germany Drug Eluting Stent Market by Application
6.1.2 Germany Drug Eluting Stent Market by Coating Type
6.1.2.1 Germany Drug Eluting Stent Market by Polymer-based Coating Type
6.1.2.2 Germany Drug Eluting Stent Market by Polymer-free Coating Type
6.2 UK Drug Eluting Stent Market
6.2.1 UK Drug Eluting Stent Market by Application
6.2.2 UK Drug Eluting Stent Market by Coating Type
6.2.2.1 UK Drug Eluting Stent Market by Polymer-based Coating Type
6.2.2.2 UK Drug Eluting Stent Market by Polymer-free Coating Type
6.3 France Drug Eluting Stent Market
6.3.1 France Drug Eluting Stent Market by Application
6.3.2 France Drug Eluting Stent Market by Coating Type
6.3.2.1 France Drug Eluting Stent Market by Polymer-based Coating Type
6.3.2.2 France Drug Eluting Stent Market by Polymer-free Coating Type
6.4 Russia Drug Eluting Stent Market
6.4.1 Russia Drug Eluting Stent Market by Application
6.4.2 Russia Drug Eluting Stent Market by Coating Type
6.4.2.1 Russia Drug Eluting Stent Market by Polymer-based Coating Type
6.4.2.2 Russia Drug Eluting Stent Market by Polymer-free Coating Type
6.5 Spain Drug Eluting Stent Market
6.5.1 Spain Drug Eluting Stent Market by Application
6.5.2 Spain Drug Eluting Stent Market by Coating Type
6.5.2.1 Spain Drug Eluting Stent Market by Polymer-based Coating Type
6.5.2.2 Spain Drug Eluting Stent Market by Polymer-free Coating Type
6.6 Italy Drug Eluting Stent Market
6.6.1 Italy Drug Eluting Stent Market by Application
6.6.2 Italy Drug Eluting Stent Market by Coating Type
6.6.2.1 Italy Drug Eluting Stent Market by Polymer-based Coating Type
6.6.2.2 Italy Drug Eluting Stent Market by Polymer-free Coating Type
6.7 Rest of Europe Drug Eluting Stent Market
6.7.1 Rest of Europe Drug Eluting Stent Market by Application
6.7.2 Rest of Europe Drug Eluting Stent Market by Coating Type
6.7.2.1 Rest of Europe Drug Eluting Stent Market by Polymer-based Coating Type
6.7.2.2 Rest of Europe Drug Eluting Stent Market by Polymer-free Coating Type
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Mergers & Acquisition:
7.1.6 SWOT Analysis
7.2 Boston Scientific Corporation
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 SWOT Analysis
7.3 Terumo Corporation
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Partnerships, Collaborations & Agreements:
7.3.6 SWOT Analysis
7.4 Medtronic PLC
7.4.1 Company overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent strategies and developments:
7.4.5.1 Trials and Approvals:
7.4.5.2 Product Launches and Product Expansions:
7.4.6 SWOT Analysis
7.5 Biosensors International Group, Ltd. (Blue Sail Medical Co., Ltd.)
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Trials and Approvals:
7.5.3 SWOT Analysis
7.6 Cook Medical, Inc. (Cook Group)
7.6.1 Company Overview
7.6.2 SWOT Analysis
7.7 B. Braun Melsungen AG
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.7.5 SWOT Analysis
7.8 Biotronik SE & Co. KG
7.8.1 Company Overview
7.8.2 SWOT Analysis
7.9 Lepu Medical Technology Co., Ltd
7.9.1 Company Overview
7.9.2 SWOT Analysis
7.10. Alvimedica
7.10.1 Company Overview
7.10.2 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings